Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review

被引:41
|
作者
Goode, Adam P. [4 ,5 ]
Coeytaux, Remy R. [7 ,8 ]
Maslow, Gary R. [1 ,2 ]
Davis, Naomi [1 ]
Hill, Sherika [1 ]
Namdari, Behrouz [1 ]
LaPointe, Nancy M. Allen [3 ,9 ]
Befus, Deanna [8 ]
Lallinger, Kathryn R. [5 ,10 ]
Bowen, Samantha E. [6 ]
Kosinski, Andrzej [5 ]
McBroom, Amanda J. [5 ,10 ]
Sanders, Gillian D. [5 ,10 ]
Kemper, Alex R. [11 ]
机构
[1] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA
[2] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA
[3] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA
[4] Duke Univ, Sch Med, Duke Orthopaed Surg, Durham, NC 27706 USA
[5] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27706 USA
[6] Duke Univ, Sch Med, Duke Ctr Autism & Brain Dev, Durham, NC 27706 USA
[7] Wake Forest Univ, Sch Med, Dept Family & Community Med, Winston Salem, NC 27109 USA
[8] Wake Forest Univ, Sch Med, Ctr Integrat Med, Winston Salem, NC 27109 USA
[9] Premier Inc, Charlotte, NC USA
[10] Duke Evidence Based Practice Ctr, Durham, NC USA
[11] Nationwide Childrens Hosp, Div Ambulatory Pediat, 700 Childrens Dr,LAC5411, Columbus, OH 43205 USA
基金
美国医疗保健研究与质量局;
关键词
DEFICIT HYPERACTIVITY DISORDER; PLACEBO-CONTROLLED TRIAL; FAMILY-SCHOOL INTERVENTION; RANDOMIZED CLINICAL-TRIAL; PROSPECTIVE FOLLOW-UP; OMEGA3; FATTY-ACIDS; DOUBLE-BLIND; YOUNG-CHILDREN; PSYCHOEDUCATION PROGRAM; GINKGO-BILOBA;
D O I
10.1542/peds.2018-0094
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
CONTEXT: Nonpharmacologic treatments for attention-deficit/hyperactivity disorder (ADHD) encompass a range of care approaches from structured behavioral interventions to complementary medicines. OBJECTIVES: To assess the comparative effectiveness of nonpharmacologic treatments for ADHD among individuals 17 years of age and younger. DATA SOURCES: PubMed, Embase, PsycINFO, and Cochrane Database of Systematic Reviews for relevant English-language studies published from January 1, 2009 through November 7, 2016. STUDY SELECTION: We included studies that compared any ADHD nonpharmacologic treatment strategy with placebo, pharmacologic, or another nonpharmacologic treatment. DATA EXTRACTION: Study design, patient characteristics, intervention approaches, follow-up times, and outcomes were abstracted. For comparisons with at least 3 similar studies, random-effects meta-analysis was used to generate pooled estimates. RESULTS: We identified 54 studies of nonpharmacologic treatments, including neurofeedback, cognitive training, cognitive behavioral therapy, child or parent training, dietary omega fatty acid supplementation, and herbal and/or dietary approaches. No new guidance was identified regarding the comparative effectiveness of nonpharmacologic treatments. Pooled results for omega fatty acids found no significant effects for parent rating of ADHD total symptoms (n = 411; standardized mean difference -0.32; 95% confidence interval -0.80 to 0.15; I-2 = 52.4%; P = .10) or teacher-rated total ADHD symptoms (n = 287; standardized mean difference -0.08; 95% confidence interval -0.47 to 0.32; I-2 = 0.0%; P = .56). LIMITATIONS: Studies often did not reflect the primary care setting and had short follow-up periods, small sample sizes, variations in outcomes, and inconsistent reporting of comparative statistical analyses. CONCLUSIONS: Despite wide use, there are significant gaps in knowledge regarding the effectiveness of ADHD nonpharmacologic treatments.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Treatment of Attention-Deficit/Hyperactivity Disorder
    Pierce, Karen
    PEDIATRIC ANNALS, 2011, 40 (11): : 556 - 562
  • [32] Pharmacotherapy for attention-deficit/hyperactivity disorder
    Kim, Bongseog
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2019, 62 (01): : 49 - 55
  • [33] Treatment of Attention-Deficit Hyperactivity Disorder
    Kim, Young Key
    Song, Dong Ho
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (05): : 489 - 499
  • [34] Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder
    Bukstein, Oscar Gary
    Head, Jared
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (15) : 2207 - 2213
  • [35] A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
    Pouchon, Arnaud
    Nasserdine, Rayan
    Donde, Clement
    Bertrand, Antoine
    Polosan, Mircea
    Bioulac, Stephanie
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (13) : 1497 - 1509
  • [36] Systematic Review and Meta-Analyses: Safety and Efficacy of Complementary and Alternative Treatments for Pediatric Attention-Deficit/Hyperactivity Disorder
    Zulauf-McCurdy, Courtney A.
    LaCount, Patrick A.
    Shelton, Christopher R.
    Morrow, Anne S.
    Zhao, Xin A.
    Russell, Douglas
    Sibley, Margaret H.
    Arnold, L. Eugene
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2023, 44 (04) : e322 - e332
  • [37] Attention-deficit/hyperactivity disorder
    Faraone, Stephen V.
    Asherson, Philip
    Banaschewski, Tobias
    Biederman, Joseph
    Buitelaar, Jan K.
    Ramos-Quiroga, Josep Antoni
    Rohde, Luis Augusto
    Sonuga-Barke, Edmund J. S.
    Tannock, Rosemary
    Franke, Barbara
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [38] Attention-Deficit/Hyperactivity Disorder
    Banaschewski, Tobias
    Becker, Katja
    Doepfner, Manfred
    Holtmann, Martin
    Roesler, Michael
    Romanos, Marcel
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2017, 114 (09): : 149 - +
  • [39] Treatments in the pipeline for attention-deficit/hyperactivity disorder (ADHD) in adults
    Veronesi, Guilherme Fusetto
    Gabellone, Alessandra
    Tomlinson, Anneka
    Solmi, Marco
    Correll, Christoph U.
    Cortese, Samuele
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2024, 163
  • [40] Attention-deficit hyperactivity disorder
    Posner, Jonathan
    Polanczyk, Guilherme V.
    Sonuga-Barke, Edmund
    LANCET, 2020, 395 (10222) : 450 - 462